These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9707767)

  • 41. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer.
    Terris MK; Wallen EM; Stamey TA
    Urol Int; 1997; 59(4):239-42. PubMed ID: 9444742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transperineal 12-core systematic biopsy in the detection of prostate cancer.
    Kojima M; Hayakawa T; Saito T; Mitsuya H; Hayase Y
    Int J Urol; 2001 Jun; 8(6):301-7. PubMed ID: 11389746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
    Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
    Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
    [No Abstract]   [Full Text] [Related]  

  • 45. Zonal biopsy in the detection of prostate cancer in Japanese men.
    Egawa S; Matsumoto K; Shitara T; Uchida T; Kuwao S; Koshiba K
    Jpn J Clin Oncol; 1998 Jan; 28(1):20-6. PubMed ID: 9491137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The outcome of elevated prostate specific antigen and transrectal ultrasound guided prostatic biopsy in detecting carcinoma of the prostate: initial experience in Sri Lanka.
    Samarasinghe UC; Perera ND; Lokuhetty D
    Ceylon Med J; 2004 Jun; 49(2):67-8. PubMed ID: 15334806
    [No Abstract]   [Full Text] [Related]  

  • 47. PSA screening for prostate cancer: the current controversy.
    de Koning HJ; Schröder FH
    Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
    [No Abstract]   [Full Text] [Related]  

  • 48. [The prostate-specific antigen in the early recognition of prostate carcinoma].
    Wolff JM; Jakse G
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1508-14. PubMed ID: 8983908
    [No Abstract]   [Full Text] [Related]  

  • 49. Screening for prostate cancer.
    Neal DE; Donovan JL
    Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
    [No Abstract]   [Full Text] [Related]  

  • 50. Editorial comment.
    Schilling D; Stenzl A
    J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging.
    Halpern EJ; Ramey JR; Strup SE; Frauscher F; McCue P; Gomella LG
    Cancer; 2005 Dec; 104(11):2373-83. PubMed ID: 16240450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The changing role of transrectal ultrasound in the diagnosis of prostate cancer.
    Clements R
    Clin Radiol; 1996 Oct; 51(10):671-6. PubMed ID: 8893633
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimization of prostatic biopsy: a prospective randomized trial comparing the sextant biopsy with a 10-core biopsy. Impact of prostatic region of sampling.
    Paul R; Schöler S; van Randenborgh H; Kübler H; Alschibaja M; Busch R; Hartung R
    Urol Int; 2005; 74(3):203-8. PubMed ID: 15812204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors.
    Hernandez J; Thompson IM
    Cancer; 2005 May; 103(9):1761-2. PubMed ID: 15742337
    [No Abstract]   [Full Text] [Related]  

  • 55. PSA screening--current controversy.
    Svetec D; Thompson IM
    Ann Oncol; 1998 Dec; 9(12):1283-8. PubMed ID: 9932156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis of prostate cancer].
    Kaprin AD; Anan'ev AP; Amosov FR; Gafanov RA
    Vopr Onkol; 1999; 45(1):20-5. PubMed ID: 10941360
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnosis and markers in prostate cancer.
    Flam TA; Brawer MK; Cooper EH; Javadpour N
    Cancer; 1992 Jul; 70(1 Suppl):357-8. PubMed ID: 1376206
    [No Abstract]   [Full Text] [Related]  

  • 58. Systematic prostate biopsies are more and more often becoming saturation biopsies.
    Scattoni V
    Eur Urol; 2006 Aug; 50(2):202-4. PubMed ID: 16488531
    [No Abstract]   [Full Text] [Related]  

  • 59. [The role of TPS in the diagnosis of prostatic carcinoma].
    Panella P; Grasso-Leanza F; Scarpignato G; Pepe P
    Minerva Urol Nefrol; 1995 Dec; 47(4):167-70. PubMed ID: 8711586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of transurethral biopsy in the diagnosis of carcinoma of the prostate.
    Pósta B; Streit B; Schmauzer J; Könyves K
    Int Urol Nephrol; 1978; 10(4):301-4. PubMed ID: 730483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.